Eli Lilly’s Weight Loss, Anti-Diabetes Drug Mounjaro To Be Launched In 2025

Eli Lilly’s Weight Loss, Anti-Diabetes Drug Mounjaro To Be Launched In 2025

Mounjaro, a weekly injectable drug by Eli Lilly for treating type 2 diabetes and obesity, competes with another high-profile drug, Ozempic (manufactured by Danish drugmaker, Novo Nordisk)